DK1296947T3 - alfa-krystallinsk form af perindopril-t-butylaminsalt - Google Patents

alfa-krystallinsk form af perindopril-t-butylaminsalt

Info

Publication number
DK1296947T3
DK1296947T3 DK01954058T DK01954058T DK1296947T3 DK 1296947 T3 DK1296947 T3 DK 1296947T3 DK 01954058 T DK01954058 T DK 01954058T DK 01954058 T DK01954058 T DK 01954058T DK 1296947 T3 DK1296947 T3 DK 1296947T3
Authority
DK
Denmark
Prior art keywords
perindopril
alpha
crystalline form
butylamine salt
butylamine
Prior art date
Application number
DK01954058T
Other languages
Danish (da)
English (en)
Inventor
Stephane Beilles
Bruno Pfeiffer
Yves-Michel Ginot
Gerard Coquerel
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8852172&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1296947(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of DK1296947T3 publication Critical patent/DK1296947T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK01954058T 2000-07-06 2001-07-06 alfa-krystallinsk form af perindopril-t-butylaminsalt DK1296947T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0008793A FR2811320B1 (fr) 2000-07-06 2000-07-06 Nouvelle forme cristalline alpha du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
PCT/FR2001/002167 WO2001087835A1 (fr) 2000-07-06 2001-07-06 FORME CRISTALLINE α DU SEL DE TERT-BUTYLAMINE DU PERINDOPRIL

Publications (1)

Publication Number Publication Date
DK1296947T3 true DK1296947T3 (da) 2004-06-01

Family

ID=8852172

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01954058T DK1296947T3 (da) 2000-07-06 2001-07-06 alfa-krystallinsk form af perindopril-t-butylaminsalt

Country Status (35)

Country Link
US (2) US20030186896A1 (bg)
EP (1) EP1296947B1 (bg)
JP (2) JP3602826B2 (bg)
KR (1) KR100513570B1 (bg)
CN (1) CN1328259C (bg)
AP (1) AP1537A (bg)
AR (1) AR034124A1 (bg)
AT (1) ATE258918T1 (bg)
AU (2) AU7641801A (bg)
BG (1) BG64868B1 (bg)
BR (1) BR0112367A (bg)
CA (1) CA2415438C (bg)
CZ (1) CZ297672B6 (bg)
DE (1) DE60101968T2 (bg)
DK (1) DK1296947T3 (bg)
EA (1) EA005008B1 (bg)
EE (1) EE05268B1 (bg)
ES (1) ES2214434T3 (bg)
FR (1) FR2811320B1 (bg)
GE (1) GEP20043361B (bg)
HK (1) HK1055425A1 (bg)
HR (1) HRP20030077B1 (bg)
ME (1) ME00443B (bg)
MX (1) MXPA02012949A (bg)
NO (1) NO323447B1 (bg)
NZ (1) NZ523173A (bg)
OA (1) OA12304A (bg)
PL (1) PL206359B1 (bg)
PT (1) PT1296947E (bg)
RS (1) RS50915B (bg)
SK (1) SK285714B6 (bg)
TR (1) TR200400238T4 (bg)
UA (1) UA57188C2 (bg)
WO (1) WO2001087835A1 (bg)
ZA (1) ZA200210092B (bg)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2811319B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline beta du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2811318B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline gamma du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2838648B1 (fr) * 2002-04-18 2004-05-21 Servier Lab Nouveau sel de perindopril et les compositions pharmaceutiques qui le contiennent
GB2395195A (en) 2002-11-18 2004-05-19 Cipla Ltd Preparation of perindopril from carboxy-protected precursor, & perindopril monohydrates for use as angiotensin converting enzyme (ACE) inhibitors
DK1636185T3 (da) * 2003-06-24 2012-05-07 Servier Lab Nye krystalformer af Perindopril erbumin
WO2005037788A1 (en) * 2003-10-21 2005-04-28 Lupin Ltd. Novel method for preparation of crystalline perindopril erbumine
SI21703A (en) 2004-01-14 2005-08-31 Lek Farmacevtska Druzba Dd Inclusion complexes of perindopril, procedure of their preparation, pharmaceutical compositions containing these complexes and their application in treatment of hypertensia
ES2603856T3 (es) * 2004-03-29 2017-03-01 Les Laboratoires Servier Procedimiento para preparar una composición farmacéutica sólida
WO2005108365A1 (en) * 2004-05-07 2005-11-17 Glenmark Pharmaceuticals Limited Processes for the preparation of alpha polymorph of perindopril erbumine
US20050250706A1 (en) * 2004-05-07 2005-11-10 Glenmark Pharmaceuticals Limited Processes for the preparation of alpha polymorph of perindopril erbumine
SI21800A (sl) * 2004-05-14 2005-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nov postopek sinteze perindoprila
SI21881A (sl) 2004-10-15 2006-04-30 Diagen, Smartno Pri Ljubljani, D.O.O. Nove kristalne oblike perindopril erbumin hidratov, postopek za njihovo pripravo in farmacevtske oblike, ki vsebujejo te spojine
SG125976A1 (en) * 2005-03-11 2006-10-30 Servier Lab New gama crystalline form of perindopril tert-butylamine salt, a process for its preparation and pharmaceutical compositions containing it
SG125975A1 (en) * 2005-03-11 2006-10-30 Servier Lab New alpha crystalline form of perindopril tert-butylamine salt, a process for its preparation and pharmaceutical compositions containing it
JP2006290825A (ja) * 2005-04-13 2006-10-26 Shiono Chemical Co Ltd アルファ型ペリンドプリルエルブミンの製造法
WO2007017894A2 (en) * 2005-05-05 2007-02-15 Arch Pharmalabs Limited PREPARATION OF NOVEL CRYSTALLINE η(ETA) FORM OF PERINDOPRIL ERBUMINE
US20070032661A1 (en) * 2005-08-03 2007-02-08 Glenmark Pharmaceuticals Limited Process for the preparation of intermediates of perindopril
UA92613C2 (ru) * 2005-08-12 2010-11-25 Лек Фармасьютиклз Д.Д. Способ получения кристаллической формы d эрбумина периндоприла
JP2009505970A (ja) * 2005-08-12 2009-02-12 サンド・アクチエンゲゼルシヤフト ペリンドプリルエルブミンの新規結晶形
EP1815857A1 (en) 2006-02-02 2007-08-08 LEK Pharmaceuticals D.D. A pharmaceutical composition comprising perindopril
WO2007092758A2 (en) * 2006-02-03 2007-08-16 Dr. Reddy's Laboratories Ltd. Crystalline forms of perindopril erbumine
FR2897865B1 (fr) * 2006-02-28 2008-04-18 Servier Lab Forme cristalline beta du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2897866B1 (fr) * 2006-02-28 2008-04-18 Servier Lab Forme cristalline alpha du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
EA200600630A1 (ru) * 2006-04-20 2007-02-27 ИСМАГИЛОВ, Искандар Халиуллович ζ-ЗЕТА ФОРМА ПЕРИНДОПРИЛ ЭРБУМИНА
EP1964836A3 (en) * 2006-11-06 2008-11-19 IPCA Laboratories Limited A process for the preparation of perindopril erbumine in alpha crystalline form
GB0624090D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amine salts
GB0624084D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amino acid salts
GB0624087D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril combination salt
WO2008114270A1 (en) * 2007-03-22 2008-09-25 Aarti Healthcare Limited Process for the preparation of perindopril erbumine salt and novel polymorph (s) thereof
WO2008120241A2 (en) * 2007-03-29 2008-10-09 Ipca Laboratories Limited Novel alcohol solvates of perindopril erbumine
SI22543A (sl) * 2007-06-27 2008-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nove soli perindoprila
AU2013201812B2 (en) * 2007-06-27 2015-04-02 Les Laboratoires Servier Salts of perindopril
SI23149A (sl) * 2009-09-21 2011-03-31 Silverstone Pharma Nove benzatinske soli ACE inhibitorjev, postopek za njihovo pripravo in njihova uporaba za zdravljenje kardiovaskularnih bolezni
PT105315B (pt) 2010-09-29 2013-01-16 Inst Superior Tecnico Uma nova forma cristalina hidratada de erbumina de perindopril, métodos para a sua preparação e sua utilização em preparações farmacêuticas
CN103822996A (zh) * 2014-03-20 2014-05-28 东英（江苏）药业有限公司 一种培哚普利叔丁胺盐含量的测定方法
CN105395497B (zh) * 2015-12-04 2019-06-18 杭州新诺华医药有限公司 一种稳定的α晶型培哚普利叔丁胺片及制备方法
EP3842035A1 (en) 2019-12-23 2021-06-30 KRKA, d.d., Novo mesto Composition for the preparation of perindopril arginine granules, a method for their preparation and pharmaceutical composition comprising the granules

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2503155A2 (fr) * 1980-10-02 1982-10-08 Science Union & Cie Nouveaux imino diacides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme
FR2620744A1 (fr) * 1987-09-17 1989-03-24 Degremont Procede de traitement par l'ozone de materiaux ligno-cellulosiques, notamment de pates a papier et reacteur pour la mise en oeuvre de ce procede
FR2620703B1 (fr) * 1987-09-17 1991-10-04 Adir Procede de synthese industrielle de l'acide perhydroindole carboxylique - 2(2s, 3as, 7as). application a la synthese de carboxyalkyl dipeptides
FR2620709B1 (fr) * 1987-09-17 1990-09-07 Adir Procede de synthese industrielle du perindopril et de ses principaux intermediaires de synthese
FR2771010B1 (fr) * 1997-11-19 2003-08-15 Adir Utilisation d'une combinaison d'un inhibiteur de l'enzyme de conversion de l'angiotensine et d'un diuretique pour le traitement des desordres microcirculatoires
FR2811318B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline gamma du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2811319B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline beta du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent

Also Published As

Publication number Publication date
CN1328259C (zh) 2007-07-25
AR034124A1 (es) 2004-02-04
AU2001276418B2 (en) 2005-07-28
BG107532A (bg) 2003-12-31
CZ2003357A3 (cs) 2003-05-14
EA200300107A1 (ru) 2003-06-26
KR20030024773A (ko) 2003-03-26
ME00443B (me) 2011-10-10
OA12304A (en) 2003-12-29
FR2811320B1 (fr) 2002-08-23
DE60101968T2 (de) 2004-12-23
EE05268B1 (et) 2010-02-15
PL348492A1 (en) 2002-01-14
EA005008B1 (ru) 2004-10-28
JP2003533507A (ja) 2003-11-11
YU100402A (sh) 2003-08-29
MXPA02012949A (es) 2003-05-15
NO323447B1 (no) 2007-05-07
EE200300001A (et) 2004-08-16
AP1537A (en) 2006-01-10
PL206359B1 (pl) 2010-07-30
KR100513570B1 (ko) 2005-09-09
WO2001087835A1 (fr) 2001-11-22
ES2214434T3 (es) 2004-09-16
BR0112367A (pt) 2003-05-13
BG64868B1 (bg) 2006-07-31
CN1440387A (zh) 2003-09-03
SK1492003A3 (en) 2003-06-03
TR200400238T4 (tr) 2004-03-22
JP5016185B2 (ja) 2012-09-05
NO20030024D0 (no) 2003-01-03
RS50915B (sr) 2010-08-31
EP1296947B1 (fr) 2004-02-04
CA2415438A1 (fr) 2001-11-22
ATE258918T1 (de) 2004-02-15
US20050059609A1 (en) 2005-03-17
HK1055425A1 (en) 2004-01-09
NZ523173A (en) 2004-04-30
HRP20030077B1 (en) 2011-07-31
DE60101968D1 (de) 2004-03-11
JP3602826B2 (ja) 2004-12-15
UA57188C2 (uk) 2003-06-16
JP2005047902A (ja) 2005-02-24
AP2002002691A0 (en) 2002-12-31
HRP20030077A2 (en) 2003-04-30
GEP20043361B (en) 2004-06-10
CZ297672B6 (cs) 2007-02-28
ZA200210092B (en) 2003-12-12
NO20030024L (no) 2003-01-03
US20030186896A1 (en) 2003-10-02
PT1296947E (pt) 2004-05-31
EP1296947A1 (fr) 2003-04-02
CA2415438C (fr) 2009-01-20
FR2811320A1 (fr) 2002-01-11
SK285714B6 (sk) 2007-06-07
AU7641801A (en) 2001-11-26

Similar Documents

Publication Publication Date Title
DK1296947T3 (da) alfa-krystallinsk form af perindopril-t-butylaminsalt
FR20C1039I2 (fr) Derives de l'uk-2a
DK1360169T3 (da) Succinatsalt af O-desmethyl-venlafaxin
CY2012006I2 (el) Φωσφονικα παραγωγα γλυκοπεπτιδιων
AR028567A1 (es) Nuevos derivados de fenil-propargileter
DE50210090D1 (de) Substituierte phenylderivate
NO20030134L (no) Fremstilling av olefinderivater
AR028596A1 (es) Nuevos derivados de fenilglicina
NO20034168D0 (no) Koagulasjonsfaktor VII-derivater
DK1294715T3 (da) Quinazolinditosylatsaltforbindelser
NO20040084L (no) Peptid-baserte forbindelser
NO20026283L (no) Inhibitorer av kobberholdige aminosydaser
ATE391502T1 (de) Kristalline formen von fluvastatin-natrium
DK1458447T3 (da) Kombination af cytokrom-p450-beroende proteasinhibitorer
DK1622612T3 (da) Farmaceutisk formulering af natriumsaltet af telmitarsan
EE200300447A (et) Asendatud bensofuraan-2-karboksamiidide derivaadid
DE60107074D1 (de) Kristallin form ii von cabergolin
PT1322592E (pt) Derivados substituidos de 1-aminobutan-3-ol
ATE403646T1 (de) Aminocyclohexan-derivate
ATE382601T1 (de) Substituierte 4-aminocyclohexanolderivate
PT1392670E (pt) Derivados substituidos de c-furan-2-il-metilamina e c-tiofen-2-il-metilamina
DK1305311T3 (da) Tartratsalt af thiazolidindionderivat
NO20025453D0 (no) Retarderingsmidler for fremstilling av renset saltvann
IS7022A (is) Nýjar indólafleiður
DE60124221D1 (de) MONOHYDRAT DES CIS-LITHIUM-CYANO-4-i3-(CYCLOPENTYLOY)-4-METHOXYPHENYLöCYCLOHEXANCARBOXYLATS